The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one stock under $50 with huge potential and two that could be down big.

Two Stocks Under $50 to Sell:

onsemi (ON)

Share Price: $49.70

Spun out of Motorola in 1999 and built through a series of acquisitions, onsemi (NASDAQ: ON) is a global provider of analog chips specializing in autos, industrial applications, and power management in cloud data centers.

Why Does ON Give Us Pause?

1. Sales tumbled by 12.5% annually over the last two years, showing market trends are working against its favor during this cycle
2. Projected sales decline of 4.6% over the next 12 months indicates demand will continue deteriorating
3. High input costs result in an inferior gross margin of 42.5% that must be offset through higher volumes

onsemi is trading at $49.70 per share, or 19.6x forward P/E. To fully understand why you should be careful with ON, check out our full research report (it’s free for active Edge members).

Haemonetics (HAE)

Share Price: $49.76

With roots dating back to 1971 and a mission to improve blood-related healthcare, Haemonetics (NYSE: HAE) provides specialized medical devices and software for blood collection, processing, and management across plasma centers, blood banks, and hospitals.

Why Are We Hesitant About HAE?

1. Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
2. Subscale operations are evident in its revenue base of $1.35 billion, meaning it has fewer distribution channels than its larger rivals
3. Forecasted revenue decline of 3% for the upcoming 12 months implies demand will fall off a cliff

Haemonetics’s stock price of $49.76 implies a valuation ratio of 10x forward P/E. Check out our free in-depth research report to learn more about why HAE doesn’t pass our bar.

One Stock Under $50 to Buy:

Alignment Healthcare (ALHC)

Share Price: $17.27

Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ: ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.

Why Will ALHC Outperform?

1. Average customer growth of 40.2% over the past two years demonstrates success in acquiring new clients that could increase their spending in the future
2. Earnings per share have massively outperformed its peers over the last four years, increasing by 45.5% annually
3. Free cash flow profile has moved into break even territory, indicating the company has achieved financial self-sustainability

At $17.27 per share, Alignment Healthcare trades at 87.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.

High-Quality Stocks for All Market Conditions

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.